Innovating Works

H2020

Cerrada
HORIZON-HLTH-2024-DISEASE...
HORIZON-HLTH-2024-DISEASE-08-12: Pandemic preparedness and response: Maintaining the European partnership for pandemic preparedness
ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 3 “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to all of the following expected outcomes:
Sólo fondo perdido 0 €
Europeo
Esta convocatoria está cerrada Esta línea ya está cerrada por lo que no puedes aplicar. Cerró el pasado día 11-04-2024.
Se espera una próxima convocatoria para esta ayuda, aún no está clara la fecha exacta de inicio de convocatoria.
Por suerte, hemos conseguido la lista de proyectos financiados!
Presentación: Consorcio Consorcio: Esta ayuda está diseñada para aplicar a ella en formato consorcio..
Esta ayuda financia Proyectos:

ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 3 “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to all of the following expected outcomes:

Research funders, policymakers and the research community maintain a consolidated research and innovation framework for the European partnership for pandemic preparedness, including the Partnership’s objectives, governance and ways of working/operationalisation;Research funders, policymakers and the research community are aligned towards common objectives and have a common understanding of the long-term Strategic Research and Innovation Agenda for the Partnership;European research funders are supported by a dynamic and efficient secretariat in their coordination efforts for pandemic preparedness research;Healthcare providers, European and international stakeholders engage with the appropriate partners through the research and innovation framework for the partnership.
Scope:The COVID-19 pandemic illustrated... ver más

ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 3 “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to all of the following expected outcomes:

Research funders, policymakers and the research community maintain a consolidated research and innovation framework for the European partnership for pandemic preparedness, including the Partnership’s objectives, governance and ways of working/operationalisation;Research funders, policymakers and the research community are aligned towards common objectives and have a common understanding of the long-term Strategic Research and Innovation Agenda for the Partnership;European research funders are supported by a dynamic and efficient secretariat in their coordination efforts for pandemic preparedness research;Healthcare providers, European and international stakeholders engage with the appropriate partners through the research and innovation framework for the partnership.
Scope:The COVID-19 pandemic illustrated how unilateral research initiatives may lead to a fragmented research landscape, with substantial room for efficiency gains in the development of the highly needed evidence to guide policy actions when facing an emergency. The European partnership for pandemic preparedness is working to improve the EU’s preparedness to predict and respond to emerging infectious health threats by better coordinating funding for research and innovation at EU, national (and regional) level towards common objectives and an agreed Strategic Research and Innovation Agenda. Such a partnership contributes to building a coherent European Research Area (ERA), enabling Member States, Associated Countries and the European Commission to rapidly and jointly support research and innovation in pandemic preparedness.

The Partnership is expected to continue to build on existing pandemic preparedness networks and research infrastructures[1], and work in synergy with the Health Emergency Preparedness and Response Authority (HERA).

Proposals should foresee administrative and technical support through a secretariat to maintain and support the European partnership on pandemic preparedness.

Proposals should include all of the following activities:

Provide an efficient secretariat for the European partnership for pandemic preparednessProvide administrative and organisational support to the Members in the European partnership for pandemic preparedness;Provide strong scientific support on topics requested by the GloPID-R Chairs, scientific advisors or (working) groups;Actively engage with relevant stakeholders and initiatives in the area of pandemic preparedness, ensuring collaboration and coordination, and avoiding duplication; e.g. the Global Health EDCTP3 Joint Undertaking, GloPID-R, WHO R&D blueprint, ACT-Accelerator, etc.;Implement strong communication and dissemination activities at EU level and in Member States and Associated Countries, on the purpose, activities and outputs of the European partnership for pandemic preparedness, both outside and during epidemic/pandemic episodes;Establish coordination and collaboration with relevant initiatives related to pandemic preparedness such as HERA to ensure complementarity and avoid overlaps;As relevant, apply a cross-cutting, interdisciplinary One Health approach; This topic requires the effective contribution of social sciences and humanities (SSH) disciplines and the involvement of SSH experts, institutions as well as the inclusion of relevant SSH expertise, in order to produce meaningful and significant effects enhancing the societal impact of the related research activities.

This topic is cancelled and replaced by topic HORIZON-HLTH-2024-DISEASE-17-01 under Call HORIZON-HLTH-2024-DISEASE-17.


[1]European Research Infrastructures | European Commission (europa.eu), BY-COVID (https://by-covid.org/), ISIDORe (https://isidore-project.eu/) and PHIRI (https://www.phiri.eu/)

ver menos

Temáticas Obligatorias del proyecto: Temática principal: This topic focuses on creating a consolidated research framework for the European partnership for pandemic preparedness to improve coordination and efficiency in responding to health crises like COVID-19. It emphasizes aligning objectives, supporting research funders, engaging stakeholders, and establishing a secretariat to enhance European preparedness and response efforts.
Infectious Diseases Public Health Epidemiology Health Policy Global Health

Características del consorcio

Ámbito Europeo : La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Tipo y tamaño de organizaciones: El diseño de consorcio necesario para la tramitación de esta ayuda necesita de:

Características del Proyecto

Requisitos de diseño: Duración:
Requisitos técnicos: The expected impacts of the project include maintaining a consolidated research and innovation framework for the European partnership for pandemic preparedness, aligning stakeholders towards common objectives, providing support to research funders, enhancing engagement with healthcare providers and international stakeholders, and fostering coordination and collaboration in pandemic preparedness efforts. The goal is to improve the EU's preparedness for emerging health threats through efficient coordination and support in research and innovation initiatives. The expected impacts of the project include maintaining a consolidated research and innovation framework for the European partnership for pandemic preparedness, aligning stakeholders towards common objectives, providing support to research funders, enhancing engagement with healthcare providers and international stakeholders, and fostering coordination and collaboration in pandemic preparedness efforts. The goal is to improve the EU's preparedness for emerging health threats through efficient coordination and support in research and innovation initiatives.
¿Quieres ejemplos? Puedes consultar aquí los últimos proyectos conocidos financiados por esta línea, sus tecnologías, sus presupuestos y sus compañías.
Capítulos financiables: Los capítulos de gastos financiables para esta línea son:
Personnel costs.
Subcontracting costs.
Purchase costs.
Other cost categories.
Indirect costs.
Madurez tecnológica: La tramitación de esta ayuda requiere de un nivel tecnológico mínimo en el proyecto de TRL 9:. La tecnología está en su forma final y funciona bajo una amplia gama de condiciones. + info.
TRL esperado:

Características de la financiación

Intensidad de la ayuda: Sólo fondo perdido + info
Fondo perdido:
0% 25% 50% 75% 100%
Para el presupuesto subvencionable la intensidad de la ayuda en formato fondo perdido podrá alcanzar como minimo un 100%.
The funding rate for CSA projects is 100 % of the eligible costs for all types of organizations. The funding rate for CSA projects is 100 % of the eligible costs for all types of organizations.
Garantías:
No exige Garantías
No existen condiciones financieras para el beneficiario.

Información adicional de la convocatoria

Efecto incentivador: Esta ayuda no tiene efecto incentivador. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
No Competitiva Competitiva Muy Competitiva
No conocemos el presupuesto total de la línea
Minimis: Esta línea de financiación NO considera una “ayuda de minimis”. Puedes consultar la normativa aquí.
Certificado DNSH: Los proyectos presentados a esta línea deben de certificarse para demostrar que no causan perjuicio al medio ambiente. + info

Otras ventajas

Sello PYME: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.